|
DURICEF
|
6505-01-153-4351
|
U Cefadroxil For Oral Suspension |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0782-41
|
6505-01-153-4351
|
U Cefadroxil For Oral Suspension |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0782-41
|
6505-01-153-4351
|
U Cefadroxil For Oral Suspension |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC25010-0805-68
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
LACRISERT
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
LACRISERT
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
NDC25010-0805-68
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
LACRISERT
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
NDC25010-0805-68
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
LACRISERT
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
NDC25010-0805-68
|
6505-01-153-4360
|
Hydroxypropyl Cellulose Ophthalm |
Valeant Pharmaceuticals
|
|
Quote
|
|
MELANEX
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
NDC10812-0930-01
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
NDC10812-9300-01
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
MELANEX
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
NDC58980-0476-10
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Stratus Pharmaceuticals, Inc
|
|
Quote
|
|
NDC10812-9300-01
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
MELANEX
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
NDC58980-0476-10
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Stratus Pharmaceuticals, Inc
|
|
Quote
|
|
NDC10812-9300-01
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
MELANEX
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
NDC58980-0476-10
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Stratus Pharmaceuticals, Inc
|
|
Quote
|
|
NDC10812-9300-01
|
6505-01-153-4362
|
Us Hydroquinone Topical Solution |
Neutrogena Corp
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Baxter Pharmaceutical Products Inc.
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Baxter Pharmaceutical Products Inc.
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Baxter Pharmaceutical Products Inc.
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Baxter Pharmaceutical Products Inc.
|
|
Quote
|
|
NDC00641-0476-25
|
6505-01-153-4373
|
U Phenobarbital Sodium Injection |
Cardinal Health 100 Inc
|
|
Quote
|
|
TRANXENE TABLETS
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4390-13
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
TRANXENE TABLETS
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4390-13
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
TRANXENE TABLETS
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4390-13
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
TRANXENE TABLETS
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4390-13
|
6505-01-153-4377
|
Clorazepate Dipotassium Tablets |
Abbott Laboratories Inc.
|
|
Quote
|
|
PRINCIPEN
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250 UNIMATIC
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0972-20
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250 UNIMATIC
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0972-20
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250 UNIMATIC
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0972-20
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250 UNIMATIC
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
PRINCIPEN 250
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0972-20
|
6505-01-153-4384
|
U Ampicillin For Oral Suspension |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Ivax Corp
|
|
Quote
|
|
NDC00713-0164-12
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
G & W Laboratories, Inc.
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Ivax Corp
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Ivax Corp
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Cardinal Health 200, Llc
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Ivax Corp
|
|
Quote
|
|
NDC00182-7001-11
|
6505-01-153-4399
|
Usp Acetaminophen Suppositories |
Cardinal Health 200, Llc
|
|
Quote
|
|
VASOCIDIN
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
NDC00058-2886-10
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
NDC00058-2886-10
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
VASOCIDIN
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
NDC00058-2886-10
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
VASOCIDIN
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
NDC00058-2886-10
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
VASOCIDIN
|
6505-01-153-4405
|
Phenylephri Sulfacetamide Sodium |
Cooper Laboratories Inc
|
|
Quote
|
|
NDC00409-1559-30
|
6505-01-153-4408
|
Bupivacaine Hydrochloride Inject |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-1559-30
|
6505-01-153-4408
|
Bupivacaine Hydrochloride Inject |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-1559-30
|
6505-01-153-4408
|
Bupivacaine Hydrochloride Inject |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-1559-30
|
6505-01-153-4408
|
Bupivacaine Hydrochloride Inject |
Hospira, Inc.
|
|
Quote
|
|
CYTADREN
|
6505-01-153-4414
|
Usp Aminoglutethimide Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
CYTADREN TABLETS
|
6505-01-153-4414
|
Usp Aminoglutethimide Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
2120
|
6505-01-153-4414
|
Usp Aminoglutethimide Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-0024-30
|
6505-01-153-4414
|
Usp Aminoglutethimide Tablets |
Ciba-geigy Corp
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Aventis Pharmaceuticals Products
|
|
Quote
|
|
NDC00185-0722-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Eon Labs Inc.
|
|
Quote
|
|
NDC00686-0491-20
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Raway Pharmacal Inc
|
|
Quote
|
|
NDC51079-0491-20
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Mylan Institutional Inc.
|
|
Quote
|
|
NDC00182-1335-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00536-4776-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00536-4957-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00364-2243-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Schein Henry Inc
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00781-1974-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Sandoz Inc.
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC45963-0344-02
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Actavis Elizabeth Llc
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00536-4776-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00536-4957-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00364-2243-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Schein Henry Inc
|
|
Quote
|
|
NDC00185-0722-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Eon Labs Inc.
|
|
Quote
|
|
NDC00182-1335-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00781-1974-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Sandoz Inc.
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC45963-0344-02
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Actavis Elizabeth Llc
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00536-4776-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00536-4957-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00364-2243-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Schein Henry Inc
|
|
Quote
|
|
NDC00185-0722-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Eon Labs Inc.
|
|
Quote
|
|
NDC00182-1335-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Goldline Laboratories Inc.
|
|
Quote
|
|
NDC00781-1974-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Sandoz Inc.
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Sanofi-aventis U.s. Inc
|
|
Quote
|
|
NDC45963-0344-02
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Actavis Elizabeth Llc
|
|
Quote
|
|
NORPRAMIN
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NORPRAMIN TABLETS
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00068-0019-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Merrell Dow Pharmeceuticals Inc
|
|
Quote
|
|
NDC00536-4776-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00536-4957-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Rugby Group Inc
|
|
Quote
|
|
NDC00364-2243-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Schein Henry Inc
|
|
Quote
|
|
NDC00185-0722-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Eon Labs Inc.
|
|
Quote
|
|
NDC00182-1335-01
|
6505-01-153-4416
|
Desipramine Hydrochloride Tablet |
Goldline Laboratories Inc.
|
|
Quote
|
|
EURAX
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
NDC00072-2203-60
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
EURAX
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
NDC00072-2203-60
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
EURAX
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
NDC00072-2203-60
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
EURAX
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
NDC00072-2203-60
|
6505-01-153-4423
|
Crotamiton Lotion |
Bristol-myers Squibb Co
|
|
Quote
|
|
LEVOTHROID
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
LEVOTHROID TABLETS
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00456-1326-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-1817-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00527-1350-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Wallack, William C
|
|
Quote
|
|
LEVOTHROID
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
LEVOTHROID TABLETS
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-1817-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00456-1326-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00527-1350-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Wallack, William C
|
|
Quote
|
|
LEVOTHROID
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
LEVOTHROID TABLETS
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00456-1326-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-1817-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00527-1350-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Wallack, William C
|
|
Quote
|
|
LEVOTHROID
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
LEVOTHROID TABLETS
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00456-1326-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Forest Pharmaceuticals Inc
|
|
Quote
|
|
NDC00378-1817-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Mylan Pharmaceuticals Inc
|
|
Quote
|
|
NDC00527-1350-01
|
6505-01-153-4435
|
Usp Levothyroxine Sodium Tablets |
Wallack, William C
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Amerisourcebergen Drug Corporation
|
|
Quote
|
|
NEO-SYNEPHRINE
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE MILD STRENGTH
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Cardinal Health 100 Inc
|
|
Quote
|
|
NEO-SYNEPHRINE
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NEO-SYNEPHRINE MILD STRENGTH
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE MILD STRENGTH
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NEO-SYNEPHRINE MILD STRENGTH
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE MILD STRENGTH
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NEO-SYNEPHRINE MILD STRENGTH
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Bayer Healthcare Llc
|
|
Quote
|
|
NEO-SYNEPHRINE
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NEO-SYNEPHRINE MILD STRENGTH
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00024-1348-03
|
6505-01-153-4451
|
Phenylephrine Hydrochloride Nasa |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Glenwood Llc
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Carlton Corp
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Glenwood Llc
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Carlton Corp
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Glenwood Llc
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Carlton Corp
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Glenwood Llc
|
|
Quote
|
|
NDC00516-0051-25
|
6505-01-153-4472
|
Potassium P-aminobe |
Carlton Corp
|
|
Quote
|
|
NDC54092-0430-16
|
6505-01-153-4480
|
Furazolidone Oral Solution |
Roberts Pharmaceutical Corp
|
|
Quote
|
|
F0075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Defense Logistics Agency
|
|
Quote
|
|
ARMADOSE
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
352-002
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
NDC00075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
F0075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Defense Logistics Agency
|
|
Quote
|
|
ARMADOSE
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
352-002
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
NDC00075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
F0075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Defense Logistics Agency
|
|
Quote
|
|
ARMADOSE
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
352-002
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
NDC00075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
F0075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Defense Logistics Agency
|
|
Quote
|
|
ARMADOSE
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
352-002
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
NDC00075-3520-02
|
6505-01-153-4489
|
Usp Thyroid Tablets |
Usv Pharmaceutical Corp
|
|
Quote
|
|
SB-1004
|
6505-01-153-4504
|
Hemodialysis Concen |
Minntech Corp
|
|
Quote
|
|
SB-1004
|
6505-01-153-4504
|
Hemodialysis Concen |
Minntech Corp
|
|
Quote
|
|
SB-1004
|
6505-01-153-4504
|
Hemodialysis Concen |
Minntech Corp
|
|
Quote
|
|
SB-1004
|
6505-01-153-4504
|
Hemodialysis Concen |
Minntech Corp
|
|
Quote
|
|
NDC00003-0775-50
|
6505-01-153-4517
|
Procainamide Hydrochloride Exten |
Bristol-myers Squibb Company
|
|
Quote
|
|
NDC00003-0775-50
|
6505-01-153-4517
|
Procainamide Hydrochloride Exten |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00078-0492-05
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
NDC00093-0778-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC51672-4041-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC00093-0778-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC51672-4041-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC51672-4041-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC00093-0778-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC51672-4041-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
NDC00093-0778-01
|
6505-01-153-4524
|
Usp Carbamazepine Tablets |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Co
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
9007073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
579-2890
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Patterson Dental Supply, Inc.
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Co
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
9007073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
579-2890
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Patterson Dental Supply, Inc.
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Co
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
9007073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
579-2890
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Patterson Dental Supply, Inc.
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Co
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
9007073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
579-2890
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Patterson Dental Supply, Inc.
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Co
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
9007073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
579-2890
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Patterson Dental Supply, Inc.
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Co
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
9007073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
579-2890
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Patterson Dental Supply, Inc.
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Co
|
|
Quote
|
|
07073
|
6505-01-153-6089
|
Aluminum Chloride Oral Topical S |
Premier Dental Products Company
|
|
Quote
|
|
NDC00264-1636-00
|
6505-01-153-7639
|
And Potassium Chloride Dextrose |
B Braun Medical Inc
|
|
Quote
|
|
S-6360
|
6505-01-153-7639
|
And Potassium Chloride Dextrose |
B Braun Medical Inc
|
|
Quote
|
|
NDC00264-1636-00
|
6505-01-153-7639
|
And Potassium Chloride Dextrose |
B Braun Medical Inc
|
|
Quote
|
|
S-6360
|
6505-01-153-7639
|
And Potassium Chloride Dextrose |
B Braun Medical Inc
|
|
Quote
|
|
NDC00710-0182-24
|
6505-01-153-9548
|
Bu Phenazopyridine Hydrochloride |
Parke-davis
|
|
Quote
|
|
P-D 182
|
6505-01-153-9548
|
Bu Phenazopyridine Hydrochloride |
Parke-davis
|
|
Quote
|
|
NDC00517-3820-01
|
6505-01-153-9549
|
Usp Aminophylline Injection |
Luitpold Pharmaceuticals Inc
|
|
Quote
|
|
NDC00469-8000-40
|
6505-01-153-9549
|
Usp Aminophylline Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00467-0005-01
|
6505-01-153-9549
|
Usp Aminophylline Injection |
Invenex Laboratories
|
|
Quote
|
|
LIDEX
|
6505-01-153-9550
|
Usp Fluocinonide Ointment |
Syntex Laboratories Inc
|
|
Quote
|
|
NDC00033-2514-14
|
6505-01-153-9550
|
Usp Fluocinonide Ointment |
Syntex Laboratories Inc
|
|
Quote
|
